0001179110-19-000651.txt : 20190110 0001179110-19-000651.hdr.sgml : 20190110 20190110160633 ACCESSION NUMBER: 0001179110-19-000651 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190108 FILED AS OF DATE: 20190110 DATE AS OF CHANGE: 20190110 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vandervoort Adam C CENTRAL INDEX KEY: 0001375088 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37477 FILM NUMBER: 19520320 MAIL ADDRESS: STREET 1: 485 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Teladoc Health, Inc. CENTRAL INDEX KEY: 0001477449 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 043705970 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 BUSINESS PHONE: 2036352002 MAIL ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 FORMER COMPANY: FORMER CONFORMED NAME: Teladoc, Inc. DATE OF NAME CHANGE: 20091123 4 1 edgar.xml FORM 4 - X0306 4 2019-01-08 0 0001477449 Teladoc Health, Inc. TDOC 0001375088 Vandervoort Adam C C/O TELADOC HEALTH, INC., 2 MANHATTANVILLE ROAD, SUITE 203 PURCHASE NY 10577 0 1 0 0 Chief Legal Officer, Secretary Common Stock 2019-01-08 4 M 0 2734 8.71 A 2934 D Common Stock 2019-01-08 4 M 0 456 9.60 A 3390 D Common Stock 2019-01-08 4 M 0 913 12.21 A 4303 D Common Stock 2019-01-08 4 M 0 1447 22.30 A 5750 D Common Stock 2019-01-08 4 S 0 5500 53.80 D 200 D Employee Stock Option (right to buy) 8.71 2019-01-08 4 M 0 2734 0.00 D 2025-02-25 Common Stock 2734 5468 D Employee Stock Option (right to buy) 9.60 2019-01-08 4 M 0 456 0.00 D 2025-05-29 Common Stock 456 2278 D Employee Stock Option (right to buy) 12.21 2019-01-08 4 M 0 913 0.00 D 2026-03-07 Common Stock 913 12790 D Employee Stock Option (right to buy) 22.30 2019-01-08 4 M 0 1447 0.00 D 2027-03-03 Common Stock 1447 37615 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on June 5, 2018. The option vests as to 25% of the shares on February 25, 2016. The remainder of the shares vest in 36 equal monthly installments thereafter. The option vests as to 25% of the shares on May 29, 2016. The remainder of the shares vest in 36 equal monthly installments thereafter. The option vests as to 25% of the shares on March 7, 2017. The remainder of the shares vest in 36 equal monthly installments thereafter. The option vests as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter. /s/ Adam C. Vandervoort 2019-01-10